2Morshead CM,Van Der Kooy D.Disguising adult neural stemcells[J].CurrOpinNeurobiol,2004,14(1):125-131.
3Littlewood TJ,Bajetta E,Nortier JW,et al.Epoetin AlfaStudy Group.Effects of epoetin alfa on hematologic param-eters and quality of life in cancer patients receiving nonp-latinum chemotherapy:results of a randomized,double-blind,placebo-controlled trial[J].J Clin Oncol,2001,19(11):2865-2874.
4Acs G,Acs P,Beckwith SM,et al.Erythropoietin and eryth-ropoietin receptor expression in human cancer[J].CancerRes,2001,61(9):3561-3565.
5Lin A,Ryu J,Harvey D,et al.Low-dose warfarin does notdecrease the rate of thrombosis in patients with cervix andvulvo-vaginal cancer treated with chemotherapy,radiation,anderythropoietin[J].Gynecol Oncol,2006,102(1):98-102.
6Brines M,Grasso G,Fiordaliso F,et al.Erythropoietin med-iates tissue protection through an erythropoietin and commonsubunit heteroreceptor[J].Proc Natl Acad Sci,2004,101(41):14907-14912.
7Stohlawetz PJ,Dzirlo L,Hergovich N,et al.Effects of eryth-ropoietin on platelet reactivity and thrombopoiesis in humans[J].Blood,2000,95(9):2983-2989.
8Fisher JW.Erythropoietin:Physiology and Pharmacology Upd-ate[J].Exp Biol Med(Maywood,NJ),2003,228(1):1-14.
9Leist M,Ghezzi P,Grasso G,et al.Derivatives of Eryth-ropoietin That Are Tissue Protective But Not Erythropoietic[J].Science,2004,305(5681):239-242.
10Kirkeby A,Torup L.High-dose erythropoietin alters plateletreactivity and bleeding time in rodents in contrast to theneuroprotective variant carbamyl-erythropoietin(CEPO)[J].Thromb Haemost,2008,99(4):720-728.
